151 related articles for article (PubMed ID: 38477216)
1. Prostate tumour visualisation with PET: is image fusion with MRI the answer?
Mehawed G; Murray R; Rukin NJ; Roberts MJ
BJU Int; 2024 Apr; 133 Suppl 4():4-6. PubMed ID: 38477216
[No Abstract] [Full Text] [Related]
2. Imaging in Prostate Cancer: Magnetic Resonance Imaging and Beyond.
Ludwig DR; Fraum TJ; Fowler KJ; Ippolito JE
Mo Med; 2018; 115(2):135-141. PubMed ID: 30228705
[TBL] [Abstract][Full Text] [Related]
3. Prostate Cancer: Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging.
Ferraro DA; Burger IA
Top Magn Reson Imaging; 2020 Feb; 29(1):59-66. PubMed ID: 32015295
[TBL] [Abstract][Full Text] [Related]
4. Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET.
Koo PJ; Kwak JJ; Pokharel S; Choyke PL
Curr Oncol Rep; 2015 Dec; 17(12):56. PubMed ID: 26462919
[TBL] [Abstract][Full Text] [Related]
5. 11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer.
Wachter S; Tomek S; Kurtaran A; Wachter-Gerstner N; Djavan B; Becherer A; Mitterhauser M; Dobrozemsky G; Li S; Pötter R; Dudczak R; Kletter K
J Clin Oncol; 2006 Jun; 24(16):2513-9. PubMed ID: 16636343
[TBL] [Abstract][Full Text] [Related]
6.
Niu S; Liu Y; Ding X; Xu Y; Yu H; Feng X; Chang X; Wang H; Li J; Gong H; Ao L; Liu J; Lin M; Wang B; Ma X; Xu B; Zhang X
Prostate; 2023 Feb; 83(2):142-150. PubMed ID: 36281654
[TBL] [Abstract][Full Text] [Related]
7. Integrated
Lütje S; Cohnen J; Gomez B; Grüneisen J; Sawicki L; Rübben H; Bockisch A; Umutlu L; Pöppel TD; Wetter A
Nuklearmedizin; 2017 Jun; 56(3):73-81. PubMed ID: 28401244
[TBL] [Abstract][Full Text] [Related]
8. [
Bauman G; Martin P; Thiessen JD; Taylor R; Moussa M; Gaed M; Rachinsky I; Kassam Z; Chin J; Pautler S; Lee TY; Valliant JF; Ward A
Eur Urol Focus; 2018 Sep; 4(5):702-706. PubMed ID: 28753797
[TBL] [Abstract][Full Text] [Related]
9. Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging.
Al-Bayati M; Grueneisen J; Lütje S; Sawicki LM; Suntharalingam S; Tschirdewahn S; Forsting M; Rübben H; Herrmann K; Umutlu L; Wetter A
Urol Int; 2018; 100(2):164-171. PubMed ID: 29393268
[TBL] [Abstract][Full Text] [Related]
10. Early
Domachevsky L; Bernstine H; Goldberg N; Nidam M; Stern D; Sosna J; Groshar D
Clin Radiol; 2017 Nov; 72(11):944-950. PubMed ID: 28716214
[TBL] [Abstract][Full Text] [Related]
11. Introducing parametric fusion PET/MRI of primary prostate cancer.
Park H; Wood D; Hussain H; Meyer CR; Shah RB; Johnson TD; Chenevert T; Piert M
J Nucl Med; 2012 Apr; 53(4):546-51. PubMed ID: 22419751
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous 18F choline positron emission tomography/magnetic resonance imaging of the prostate: initial results.
Wetter A; Lipponer C; Nensa F; Beiderwellen K; Olbricht T; Rübben H; Bockisch A; Schlosser T; Heusner TA; Lauenstein TC
Invest Radiol; 2013 May; 48(5):256-62. PubMed ID: 23462678
[TBL] [Abstract][Full Text] [Related]
13.
Malaspina S; De Giorgi U; Kemppainen J; Del Sole A; Paganelli G
Radiol Med; 2018 Dec; 123(12):952-965. PubMed ID: 30116970
[TBL] [Abstract][Full Text] [Related]
14. Case of the Season: Prostate Specific Membrane Antigen (PSMA) Positron-Emission Tomography (PET)-MRI to Evaluate Neoadjuvant Radiation Therapy Response.
Chen C; Margolis DJ
Semin Roentgenol; 2021 Oct; 56(4):363-365. PubMed ID: 34688338
[No Abstract] [Full Text] [Related]
15. Comparison between
Liu Y; Dong Y; Liu J; Zhang X; Lin M; Xu B
Prostate; 2021 Dec; 81(16):1329-1336. PubMed ID: 34516670
[TBL] [Abstract][Full Text] [Related]
16. Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment.
Mapelli P; Ghezzo S; Spataro A; Bezzi C; Samanes Gajate AM; Chiti A; Picchio M
Magn Reson Imaging Clin N Am; 2023 Nov; 31(4):605-611. PubMed ID: 37741644
[TBL] [Abstract][Full Text] [Related]
17. Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with
Sobol I; Zaid HB; Haloi R; Mynderse LA; Froemming AT; Lowe VJ; Davis BJ; Kwon ED; Karnes RJ
J Urol; 2017 Jan; 197(1):129-134. PubMed ID: 27449262
[TBL] [Abstract][Full Text] [Related]
18. Whole-Body Integrated [
Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
[TBL] [Abstract][Full Text] [Related]
19. Effect of Time-of-Flight and Regularized Reconstructions on Quantitative Measurements and Qualitative Assessments in Newly Diagnosed Prostate Cancer With
Behr SC; Mollard BJ; Yang J; Flavell RR; Hawkins RA; Seo Y
Mol Imaging; 2017; 16():1536012117736703. PubMed ID: 29169313
[TBL] [Abstract][Full Text] [Related]
20. Choline-based imaging of prostate cancer with combined [
Wetter A; Grüneisen J; Fliessbach K; Lütje S; Schaarschmidt B; Umutlu L
Clin Imaging; 2017; 42():198-202. PubMed ID: 28110202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
